Roberts BM, Lambert E, Livesey JA, Wu Z, Li Y, Cragg SJ
The fact that folinic acid, even at high dose, did not change metabolic markers of methylation and/or glutathione metabolism unless it was combined with mB12 is an important finding as it has direct implication for treatment of inter-related but distinct metabolic disorders associated with ASD
The judge overseeing the group GLP-1 lawsuit issued a memorandum on which experts testimonies will be allowed to be used in the case and what test people need to provide as evidence
Retatrutide delivers broader metabolic coverage and more significant standalone weight loss through its triple-receptor design
On April 1, the FDA approved Foundayo (orforglipron), Eli Lillys once-daily oral GLP-1 receptor agonist for obesity, which is the first oral GLP-1 approved for weight management and the fastest new molecular entity approval since 2002